Global Compounding Pharmacy Market Overview And Scope:
Global Compounding Pharmacy Market Size was estimated at USD 11898.59 million in 2022 and is projected to reach USD 13983.09 million by 2028, exhibiting a CAGR of 2.73% during the forecast period.
The Global Compounding Pharmacy Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Compounding Pharmacy utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: PharMEDium Services, B. Braun Group, Fagron, Wedgewood Pharmacy, New Compounding Pharma, Medisca, Fresenius Kabi, Advanced Pharma, AIN GROUP, Nihon Chouzai, Sogo Medical, Dougherty’s Pharmacy, Apollo Pharmacy, Downing Labs, Qol Holdings, Olympia Pharmacy, PUMCH, Triangle Compounding Pharmacy, Peking University First Hospital, Affiliated Hospital of Guangdong Public Institution of Medicine, Lorraine's Pharmacy, PLAGH, Institutional Pharmacy Solutions, Ruijin Hospital, Belle Sante, Byculla PharmacyandStores, Royal Chemists, Village Compounding Pharmacy, Specialist Pharmacy
Global Compounding Pharmacy Market Segmentation
By Type, Compounding Pharmacy market has been segmented into:PIA
PAA
CUPM
PDA
SAPM
By Application, Compounding Pharmacy market has been segmented into:
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Compounding Pharmacy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Compounding Pharmacy market.
Top Key Players Covered in Compounding Pharmacy market are:
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Belle Sante
Byculla PharmacyandStores
Royal Chemists
Village Compounding Pharmacy
Specialist Pharmacy
Objective to buy this Report:
1. Compounding Pharmacy analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Compounding Pharmacy market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Compounding Pharmacy Market by Type
5.1 Compounding Pharmacy Market Overview Snapshot and Growth Engine
5.2 Compounding Pharmacy Market Overview
5.3 PIA
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 PIA: Geographic Segmentation
5.4 PAA
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 PAA: Geographic Segmentation
5.5 CUPM
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 CUPM: Geographic Segmentation
5.6 PDA
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 PDA: Geographic Segmentation
5.7 SAPM
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 SAPM: Geographic Segmentation
Chapter 6: Compounding Pharmacy Market by Application
6.1 Compounding Pharmacy Market Overview Snapshot and Growth Engine
6.2 Compounding Pharmacy Market Overview
6.3 Consumers Aged 18 and Younger
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Consumers Aged 18 and Younger: Geographic Segmentation
6.4 Consumers Aged 19 to 44
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Consumers Aged 19 to 44: Geographic Segmentation
6.5 Consumers Aged 45 to 64
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Consumers Aged 45 to 64: Geographic Segmentation
6.6 Consumers Aged 65 and Older
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Consumers Aged 65 and Older: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Compounding Pharmacy Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Compounding Pharmacy Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Compounding Pharmacy Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PHARMEDIUM SERVICES
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 B. BRAUN GROUP
7.4 FAGRON
7.5 WEDGEWOOD PHARMACY
7.6 NEW COMPOUNDING PHARMA
7.7 MEDISCA
7.8 FRESENIUS KABI
7.9 ADVANCED PHARMA
7.10 AIN GROUP
7.11 NIHON CHOUZAI
7.12 SOGO MEDICAL
7.13 DOUGHERTY’S PHARMACY
7.14 APOLLO PHARMACY
7.15 DOWNING LABS
7.16 QOL HOLDINGS
7.17 OLYMPIA PHARMACY
7.18 PUMCH
7.19 TRIANGLE COMPOUNDING PHARMACY
7.20 PEKING UNIVERSITY FIRST HOSPITAL
7.21 AFFILIATED HOSPITAL OF GUANGDONG PUBLIC INSTITUTION OF MEDICINE
7.22 LORRAINE'S PHARMACY
7.23 PLAGH
7.24 INSTITUTIONAL PHARMACY SOLUTIONS
7.25 RUIJIN HOSPITAL
7.26 BELLE SANTE
7.27 BYCULLA PHARMACYANDSTORES
7.28 ROYAL CHEMISTS
7.29 VILLAGE COMPOUNDING PHARMACY
7.30 SPECIALIST PHARMACY
Chapter 8: Global Compounding Pharmacy Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 PIA
8.2.2 PAA
8.2.3 CUPM
8.2.4 PDA
8.2.5 SAPM
8.3 Historic and Forecasted Market Size By Application
8.3.1 Consumers Aged 18 and Younger
8.3.2 Consumers Aged 19 to 44
8.3.3 Consumers Aged 45 to 64
8.3.4 Consumers Aged 65 and Older
Chapter 9: North America Compounding Pharmacy Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 PIA
9.4.2 PAA
9.4.3 CUPM
9.4.4 PDA
9.4.5 SAPM
9.5 Historic and Forecasted Market Size By Application
9.5.1 Consumers Aged 18 and Younger
9.5.2 Consumers Aged 19 to 44
9.5.3 Consumers Aged 45 to 64
9.5.4 Consumers Aged 65 and Older
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Compounding Pharmacy Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 PIA
10.4.2 PAA
10.4.3 CUPM
10.4.4 PDA
10.4.5 SAPM
10.5 Historic and Forecasted Market Size By Application
10.5.1 Consumers Aged 18 and Younger
10.5.2 Consumers Aged 19 to 44
10.5.3 Consumers Aged 45 to 64
10.5.4 Consumers Aged 65 and Older
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Compounding Pharmacy Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 PIA
11.4.2 PAA
11.4.3 CUPM
11.4.4 PDA
11.4.5 SAPM
11.5 Historic and Forecasted Market Size By Application
11.5.1 Consumers Aged 18 and Younger
11.5.2 Consumers Aged 19 to 44
11.5.3 Consumers Aged 45 to 64
11.5.4 Consumers Aged 65 and Older
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Compounding Pharmacy Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 PIA
12.4.2 PAA
12.4.3 CUPM
12.4.4 PDA
12.4.5 SAPM
12.5 Historic and Forecasted Market Size By Application
12.5.1 Consumers Aged 18 and Younger
12.5.2 Consumers Aged 19 to 44
12.5.3 Consumers Aged 45 to 64
12.5.4 Consumers Aged 65 and Older
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Compounding Pharmacy Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 PIA
13.4.2 PAA
13.4.3 CUPM
13.4.4 PDA
13.4.5 SAPM
13.5 Historic and Forecasted Market Size By Application
13.5.1 Consumers Aged 18 and Younger
13.5.2 Consumers Aged 19 to 44
13.5.3 Consumers Aged 45 to 64
13.5.4 Consumers Aged 65 and Older
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Compounding Pharmacy Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 PIA
14.4.2 PAA
14.4.3 CUPM
14.4.4 PDA
14.4.5 SAPM
14.5 Historic and Forecasted Market Size By Application
14.5.1 Consumers Aged 18 and Younger
14.5.2 Consumers Aged 19 to 44
14.5.3 Consumers Aged 45 to 64
14.5.4 Consumers Aged 65 and Older
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Compounding Pharmacy Scope:
|
Report Data
|
Compounding Pharmacy Market
|
|
Compounding Pharmacy Market Size in 2025
|
USD XX million
|
|
Compounding Pharmacy CAGR 2025 - 2032
|
XX%
|
|
Compounding Pharmacy Base Year
|
2024
|
|
Compounding Pharmacy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
PharMEDium Services, B. Braun Group, Fagron, Wedgewood Pharmacy, New Compounding Pharma, Medisca, Fresenius Kabi, Advanced Pharma, AIN GROUP, Nihon Chouzai, Sogo Medical, Dougherty’s Pharmacy, Apollo Pharmacy, Downing Labs, Qol Holdings, Olympia Pharmacy, PUMCH, Triangle Compounding Pharmacy, Peking University First Hospital, Affiliated Hospital of Guangdong Public Institution of Medicine, Lorraine's Pharmacy, PLAGH, Institutional Pharmacy Solutions, Ruijin Hospital, Belle Sante, Byculla PharmacyandStores, Royal Chemists, Village Compounding Pharmacy, Specialist Pharmacy.
|
|
Key Segments
|
By Type
PIA
PAA
CUPM
PDA
SAPM
By Applications
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
|
